252 related articles for article (PubMed ID: 12043847)
1. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
Elkon H; Melamed E; Offen D
Cell Mol Neurobiol; 2001 Dec; 21(6):771-81. PubMed ID: 12043847
[TBL] [Abstract][Full Text] [Related]
2. Failure of the ubiquitin-proteasome system in Parkinson's disease.
McNaught KS; Olanow CW; Halliwell B; Isacson O; Jenner P
Nat Rev Neurosci; 2001 Aug; 2(8):589-94. PubMed ID: 11484002
[No Abstract] [Full Text] [Related]
3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal function is impaired in substantia nigra in Parkinson's disease.
McNaught KS; Jenner P
Neurosci Lett; 2001 Jan; 297(3):191-4. PubMed ID: 11137760
[TBL] [Abstract][Full Text] [Related]
5. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
[TBL] [Abstract][Full Text] [Related]
6. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
Rideout HJ; Larsen KE; Sulzer D; Stefanis L
J Neurochem; 2001 Aug; 78(4):899-908. PubMed ID: 11520910
[TBL] [Abstract][Full Text] [Related]
7. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
8. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.
Petrucelli L; O'Farrell C; Lockhart PJ; Baptista M; Kehoe K; Vink L; Choi P; Wolozin B; Farrer M; Hardy J; Cookson MR
Neuron; 2002 Dec; 36(6):1007-19. PubMed ID: 12495618
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
McLean PJ; Kawamata H; Hyman BT
Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
[TBL] [Abstract][Full Text] [Related]
10. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA
Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365
[TBL] [Abstract][Full Text] [Related]
11. Parkin is metabolized by the ubiquitin/proteosome system.
Choi P; Ostrerova-Golts N; Sparkman D; Cochran E; Lee JM; Wolozin B
Neuroreport; 2000 Aug; 11(12):2635-8. PubMed ID: 10976934
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease.
Elkon H; Melamed E; Offen D
J Mol Neurosci; 2004; 24(3):387-400. PubMed ID: 15655261
[TBL] [Abstract][Full Text] [Related]
13. Are ubiquitination pathways central to Parkinson's disease?
Giasson BI; Lee VM
Cell; 2003 Jul; 114(1):1-8. PubMed ID: 12859888
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
[TBL] [Abstract][Full Text] [Related]
15. Does proteasome [corrected] inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration?
Setsuie R; Kabuta T; Wada K
J Pharmacol Sci; 2005 Mar; 97(3):457-60. PubMed ID: 15764834
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
18. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
Folco EJ; Koren G
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
[TBL] [Abstract][Full Text] [Related]
19. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.
Stefanis L; Larsen KE; Rideout HJ; Sulzer D; Greene LA
J Neurosci; 2001 Dec; 21(24):9549-60. PubMed ID: 11739566
[TBL] [Abstract][Full Text] [Related]
20. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
